Showing results (2641-2650 of 6,166) with videos related to
Sort By:
Pageof 617
Nature Medicine|June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trialSteven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.Nature Medicine|May 15, 2024
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Jihong Liu, Jing Wang, et al.Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.Nature Medicine|August 21, 2023
Postacute sequelae of COVID-19 at 2 yearsBenjamin Bowe, Yan Xie, Ziyad Al-AlyNature Medicine|August 17, 2023
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trialYi Lin, Noopur S Raje, Jesús G Berdeja, et al.Nature Medicine|August 14, 2023
Cerebellar deep brain stimulation for chronic post-stroke motor rehabilitation: a phase I trialKenneth B Baker, Ela B Plow, Sean Nagel, et al.Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.Nature Medicine|October 9, 2023
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trialRobert E MacLaren, M Dominik Fischer, James A Gow, et al.Pageof 617